PTPNS protein family pseudogene

The "PTPNS protein family pseudogene" (ENSG00000242324) is a **pseudogene**—a DNA segment that resembles a functional gene but is nonfunctional and does not encode an active protein product[1][2][7]. Pseudogenes typically arise from duplication or retrotransposition events involving functional genes, but accumulate disabling mutations (such as frameshifts or premature stop codons) and lack regulatory elements necessary for protein coding[2]. While some pseudogenes can be transcribed as RNA and may play roles as gene expression regulators or microRNA decoys, the PTPNS protein family pseudogene is annotated only as a "pseudogene" with no evidence of functional protein or therapeutic relevance[1][7]. This gene is not a recognized therapeutic target or receptor, and does not fall into classes like enzyme, transporter, receptor, or transcription factor[1][2][7]. It should not be included as a drug or biomarker target in standard molecular databases. There is no evidence linking this pseudogene to disease mechanisms, drug interactions, or clinical use. The entry appears in databases only as a pseudogene without additional biological or pharmaceutical relevance[1][7]. **Additional notes:** - **is_incorrect** is marked **true** due to this entity being a nonfunctional pseudogene, not a druggable or therapeutically relevant molecular target[2][10]. - The closest functional relatives would be protein tyrosine phosphatases (such as PTPN20 or PTPN11), some of which are therapeutic targets, but this specific entry lacks any such functional properties[1][3][9]. - Any functional or drug-interaction data for protein tyrosine phosphatases *do not* apply to this pseudogene[1][2][3][7].

Other names

PTPNS (protein tyrosine phosphatase, non-receptor type substrate 1) protein family pseudogene